Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW) Share Price

Price $2.44 on 02-09-2026 at 18:35:10
Change $-0.01 -0.41%
Buy $2.46
Sell $2.44
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 98,052.00 at $2.44
Day's Volume: 483,878
Last Close: $2.44
Open: $2.42
ISIN: GG00BKTRRM22
Day's Range $2.42 - $2.45
52wk Range: $1.43 - $2.64
Market Capitalisation: $786.10m
VWAP: $2.445826
Shares in Issue: 322.17m

Rtw Biotech (RTW) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 98,052 $2.44 Uncrossing Trade
 16:35:04 - 02-Sep-26
Buy* 1,757 $2.45 Automatic Execution
 16:29:49 - 02-Sep-26
Sell* 1,757 $2.44 Automatic Execution
 16:29:45 - 02-Sep-26
Buy* 20,000 $2.45 Automatic Execution
 16:29:45 - 02-Sep-26
Unknown* 11 $2.44 OTC Trade
 16:29:00 - 02-Sep-26
Unknown* 76 $2.44 OTC Trade
 16:24:45 - 02-Sep-26
Unknown* 440 $2.44 OTC Trade
 16:20:38 - 02-Sep-26
Sell* 2,100 $2.44 Automatic Execution
 16:20:01 - 02-Sep-26
Buy* 98 $2.44 Automatic Execution
 16:19:53 - 02-Sep-26
Buy* 10,000 $2.44 Automatic Execution
 16:19:53 - 02-Sep-26
See more Rtw Biotech trades

Rtw Biotech (RTW) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Sep 2026 (Wed) 2.42 2.45 2.42 2.44 483,878
1st Sep 2026 (Tue) 2.52 2.52 2.39 2.45 330,868
31st Aug 2026 (Mon) 2.52 2.52 2.52 2.52 0
28th Aug 2026 (Fri) 2.52 2.54 2.52 2.52 416,120
27th Aug 2026 (Thu) 2.54 2.54 2.51 2.53 245,314
26th Aug 2026 (Wed) 2.50 2.55 2.50 2.53 698,801
25th Aug 2026 (Tue) 2.51 2.56 2.51 2.53 708,046
24th Aug 2026 (Mon) 2.55 2.58 2.51 2.54 493,835
21st Aug 2026 (Fri) 2.58 2.59 2.57 2.58 109,593
20th Aug 2026 (Thu) 2.57 2.61 2.57 2.58 137,127
19th Aug 2026 (Wed) 2.59 2.60 2.55 2.60 549,148
18th Aug 2026 (Tue) 2.57 2.57 2.55 2.56 175,375
17th Aug 2026 (Mon) 2.58 2.58 2.54 2.57 418,415
14th Aug 2026 (Fri) 2.64 2.64 2.55 2.58 497,482
13th Aug 2026 (Thu) 2.58 2.61 2.57 2.61 653,546
12th Aug 2026 (Wed) 2.55 2.59 2.53 2.53 284,412
11th Aug 2026 (Tue) 2.50 2.58 2.50 2.57 402,632
10th Aug 2026 (Mon) 2.52 2.52 2.50 2.51 65,910
7th Aug 2026 (Fri) 2.50 2.52 2.48 2.51 330,320
6th Aug 2026 (Thu) 2.49 2.50 2.45 2.49 93,892
5th Aug 2026 (Wed) 2.48 2.49 2.47 2.49 247,784
4th Aug 2026 (Tue) 2.48 2.49 2.46 2.48 210,780
3rd Aug 2026 (Mon) 2.47 2.49 2.45 2.45 143,991
See more Rtw Biotech price history

Rtw Biotech (RTW) Regulatory News

Date Source Headline
2nd Sep 2026 7:00 am RNS Transaction in Own Shares
1st Sep 2026 7:01 am RNS Total Voting Rights
1st Sep 2026 7:00 am RNS Notice of 2026 Interim Results & Webinars
19th Aug 2026 7:01 am RNS BioMarin to acquire Alesta Therapeutics
19th Aug 2026 7:00 am RNS Change of Corporate Broker
18th Aug 2026 7:00 am RNS Transaction in Own Shares
14th Aug 2026 7:00 am RNS Monthly Valuation Update and Factsheet
12th Aug 2026 7:00 am RNS Avere Therapeutics to merge with NextCure Inc.
5th Aug 2026 7:00 am RNS Obsidian Therapeutics merges with Galera
3rd Aug 2026 7:00 am RNS Total Voting Rights
See more Rtw Biotech regulatory news

Rtw Biotech (RTW) Share News

IN BRIEF: RTW Biotech Opportunities get 0.2% uplift from Alesta deal

19th Aug 2026 12:40

RTW Biotech Opportunities Ltd - investor in life sciences sector - Notes the announcement by BioMarin Pharmaceuticals Inc that it has agreed to buy RTW Biotech portfolio holding Alesta Therapeutics, which will give net asset value a boost. BioMarin will pay USD275 million upfront in cash for Alesta's lead asset, ALE1, which RTW says represents a 41% uplift on its own carrying value for Alesta. This will result in a USD1.6 million, or 0.2%, addition to RTW Biotech's net asset value as of July 31. Read More

RTW Biotech's Avere to go public in US in reverse merger with NextCure

12th Aug 2026 09:38

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday noted that portfolio holding Avere Therapeutics will go public via a reverse merger with Nasdaq-listed NextCure Inc. Read More

RTW Biotech investee Obsidian debuts on Nasdaq after Galera deal

5th Aug 2026 14:00

(Alliance News) - RTW Biotech Opportunities Ltd on Wednesday noted its investee Obsidian Therapeutics Inc has gone public on the Nasdaq in New York following a reverse merger with Galera Therapeutics Inc. Read More

EARNINGS AND TRADING: Hargreaves Services results beat guidance

29th Jul 2026 17:51

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

RTW Biotech invests USD1.4 million in Lycia Therapeutics' series D

26th Jun 2026 09:51

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has made an additional investment in portfolio company Lycia Therapeutics Inc as part of its series D financing round. Read More

See more Rtw Biotech news
FTSE 100 Latest
Value10,756.45
Change-32.83

Login to your account

Forgot Password?

Not Registered